HIV

Latest News

Biktarvy Indication Expanded by FDA for Resistant HIV
Biktarvy Indication Expanded by FDA for Resistant HIV

February 27th 2024

The new approval is supported by the phase 3 Study 4030, which evaluated the efficacy, safety, and tolerability profile of Biktarvy in a broad range of people with HIV-1 with or without pre-existing NRTI resistance, including those with the M184V/I resistance.

Digital Health Tools Could Increase PrEP Uptake Among Young Individuals At-Risk For HIV
Digital Health Tools Could Increase PrEP Uptake Among Young Individuals At-Risk For HIV

February 26th 2024

Plasma Biomarkers May Predict Brain Health in Women With HIV
Plasma Biomarkers May Predict Brain Health in Women With HIV

December 8th 2023

FDA Grants Tentative Approval to Generic Triumpeq PD for Children With HIV
FDA Grants Tentative Approval to Generic Triumpeq PD for Children With HIV

September 14th 2023

Three-Dose Hepatitis B Vaccine Regimen Can Protect Those With HIV
Three-Dose Hepatitis B Vaccine Regimen Can Protect Those With HIV

January 18th 2023

More News

© 2024 MJH Life Sciences

All rights reserved.